Ontology highlight
ABSTRACT: Introduction
Risk factors for thromboembolic events in patients with dialysis-dependent chronic kidney disease (CKD) receiving roxadustat are unknown. Iron deficiency has been reported as a risk factor for thrombosis in the general population.Methods
Thromboembolic events with onset before and after week 12 in patients receiving roxadustat were evaluated in this pooled analysis of four global phase 3 trials, PYRENEES, SIERRAS, HIMALAYAS, and ROCKIES. Baseline risk factors for thromboembolic events were investigated by Cox regression analyses. Nested case-control analyses with matched pairs of case-control data explored the relationship between thromboembolic events and last known laboratory parameters before event onset.Results
Of 2354 patients, 1026 thromboembolic
SUBMITTER: Hamano T
PROVIDER: S-EPMC10960763 | biostudies-literature | 2024 Apr
REPOSITORIES: biostudies-literature